DK1784402T3 - Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling - Google Patents
Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstillingInfo
- Publication number
- DK1784402T3 DK1784402T3 DK05781131.7T DK05781131T DK1784402T3 DK 1784402 T3 DK1784402 T3 DK 1784402T3 DK 05781131 T DK05781131 T DK 05781131T DK 1784402 T3 DK1784402 T3 DK 1784402T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolo
- pyridine derivatives
- processes
- preparation
- well
- Prior art date
Links
- SRSKXJVMVSSSHB-UHFFFAOYSA-N 1h-pyrrolo[3,2-c]pyridine Chemical class N1=CC=C2NC=CC2=C1 SRSKXJVMVSSSHB-UHFFFAOYSA-N 0.000 title abstract 3
- 102100021904 Potassium-transporting ATPase alpha chain 1 Human genes 0.000 abstract 2
- 108010083204 Proton Pumps Proteins 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20040070536 | 2004-09-03 | ||
| PCT/KR2005/002924 WO2006025714A1 (en) | 2004-09-03 | 2005-09-03 | PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1784402T3 true DK1784402T3 (da) | 2011-11-14 |
Family
ID=36000316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05781131.7T DK1784402T3 (da) | 2004-09-03 | 2005-09-03 | Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8148529B2 (enExample) |
| EP (1) | EP1784402B1 (enExample) |
| JP (1) | JP5126830B2 (enExample) |
| KR (1) | KR100946219B1 (enExample) |
| CN (1) | CN101018788B (enExample) |
| AT (1) | ATE518858T1 (enExample) |
| AU (1) | AU2005280738B2 (enExample) |
| BR (1) | BRPI0514843A (enExample) |
| CA (1) | CA2578880C (enExample) |
| DK (1) | DK1784402T3 (enExample) |
| ES (1) | ES2367312T3 (enExample) |
| MX (1) | MX2007002214A (enExample) |
| PL (1) | PL1784402T3 (enExample) |
| PT (1) | PT1784402E (enExample) |
| RU (1) | RU2378275C2 (enExample) |
| WO (1) | WO2006025714A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008017466A1 (en) * | 2006-08-08 | 2008-02-14 | Nycomed Gmbh | Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| JP5802898B2 (ja) | 2009-07-09 | 2015-11-04 | ラクオリア創薬株式会社 | 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 |
| GB2517908A (en) * | 2013-08-14 | 2015-03-11 | Kalvista Pharmaceuticals Ltd | Bicyclic inhibitors |
| TWI636047B (zh) | 2013-08-14 | 2018-09-21 | 英商卡爾維斯塔製藥有限公司 | 雜環衍生物 |
| CN103626767A (zh) * | 2013-12-04 | 2014-03-12 | 上海药明康德新药开发有限公司 | 区域选择性的氮杂吲哚及其合成方法 |
| GB201421083D0 (en) | 2014-11-27 | 2015-01-14 | Kalvista Pharmaceuticals Ltd | Enzyme inhibitors |
| JP7511326B2 (ja) | 2015-10-09 | 2024-07-05 | ウェイブ ライフ サイエンシズ リミテッド | オリゴヌクレオチド組成物およびその方法 |
| SG11201809922YA (en) | 2016-05-31 | 2018-12-28 | Kalvista Pharmaceuticals Ltd | Pyrazole derivatives as plasma kallikrein inhibitors |
| GB201609607D0 (en) | 2016-06-01 | 2016-07-13 | Kalvista Pharmaceuticals Ltd | Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts |
| RS63069B1 (sr) | 2017-11-29 | 2022-04-29 | Kalvista Pharmaceuticals Ltd | Dozni oblici koji sadrže inhibitor kalikreina plazme |
| GB201719881D0 (en) | 2017-11-29 | 2018-01-10 | Kalvista Pharmaceuticals Ltd | Solid forms of plasma kallikrein inhibitor and salts thereof |
| CN114206852A (zh) | 2019-08-09 | 2022-03-18 | 卡尔维斯塔制药有限公司 | 血浆激肽释放酶抑制剂 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3269604D1 (en) | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
| JP3465827B2 (ja) * | 1993-02-24 | 2003-11-10 | 株式会社日清製粉グループ本社 | アザインドール誘導体およびこれを有効成分とする抗潰瘍薬 |
| US5451566A (en) * | 1993-11-17 | 1995-09-19 | Zeneca Limited | Herbicidal pyrrolopyridine compounds |
| CN1044811C (zh) * | 1994-01-19 | 1999-08-25 | 三共株式会社 | 吡咯并哒嗪衍生物 |
| CN1102144C (zh) | 1994-08-13 | 2003-02-26 | 株式会社柳韩洋行 | 新的嘧啶衍生物及其制备方法 |
| EP0849274A1 (en) * | 1996-12-20 | 1998-06-24 | Schering Aktiengesellschaft | Bissteroidal compounds and their use for the preparation of chiral complexes |
| SE9700661D0 (sv) | 1997-02-25 | 1997-02-25 | Astra Ab | New compounds |
| SE9704404D0 (sv) | 1997-11-28 | 1997-11-28 | Astra Ab | New compounds |
| UA59433C2 (uk) * | 1998-01-27 | 2003-09-15 | Авентіс Фармасьютікалс Продактс Інк. | ЗАМІЩЕНІ ОКСОАЗАГЕТЕРОЦИКЛІЧНІ ІНГІБІТОРИ ФАКТОРА Хa ТА ПРОМІЖНІ СПОЛУКИ ДЛЯ ЇХ ОТРИМАННЯ |
| ATE231862T1 (de) | 1998-09-23 | 2003-02-15 | Altana Pharma Ag | Tetrahydropyridoether |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US20040235867A1 (en) | 2001-07-24 | 2004-11-25 | Bilodeau Mark T. | Tyrosine kinase inhibitors |
-
2005
- 2005-09-03 CN CN200580029382XA patent/CN101018788B/zh not_active Expired - Fee Related
- 2005-09-03 EP EP05781131A patent/EP1784402B1/en not_active Expired - Lifetime
- 2005-09-03 ES ES05781131T patent/ES2367312T3/es not_active Expired - Lifetime
- 2005-09-03 DK DK05781131.7T patent/DK1784402T3/da active
- 2005-09-03 BR BRPI0514843-0A patent/BRPI0514843A/pt not_active Application Discontinuation
- 2005-09-03 CA CA2578880A patent/CA2578880C/en not_active Expired - Fee Related
- 2005-09-03 AT AT05781131T patent/ATE518858T1/de active
- 2005-09-03 RU RU2007112108/04A patent/RU2378275C2/ru not_active IP Right Cessation
- 2005-09-03 WO PCT/KR2005/002924 patent/WO2006025714A1/en not_active Ceased
- 2005-09-03 KR KR1020050082008A patent/KR100946219B1/ko not_active Expired - Fee Related
- 2005-09-03 MX MX2007002214A patent/MX2007002214A/es active IP Right Grant
- 2005-09-03 JP JP2007529714A patent/JP5126830B2/ja not_active Expired - Fee Related
- 2005-09-03 US US11/574,393 patent/US8148529B2/en not_active Expired - Fee Related
- 2005-09-03 PT PT05781131T patent/PT1784402E/pt unknown
- 2005-09-03 AU AU2005280738A patent/AU2005280738B2/en not_active Ceased
- 2005-09-03 PL PL05781131T patent/PL1784402T3/pl unknown
-
2011
- 2011-11-15 US US13/296,378 patent/US8513277B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101018788A (zh) | 2007-08-15 |
| US20090005409A1 (en) | 2009-01-01 |
| BRPI0514843A (pt) | 2008-06-24 |
| KR20060051002A (ko) | 2006-05-19 |
| CA2578880C (en) | 2013-01-29 |
| RU2007112108A (ru) | 2008-10-10 |
| HK1105977A1 (en) | 2008-02-29 |
| US8148529B2 (en) | 2012-04-03 |
| EP1784402A1 (en) | 2007-05-16 |
| ES2367312T3 (es) | 2011-11-02 |
| JP5126830B2 (ja) | 2013-01-23 |
| US8513277B2 (en) | 2013-08-20 |
| RU2378275C2 (ru) | 2010-01-10 |
| EP1784402A4 (en) | 2009-12-23 |
| PT1784402E (pt) | 2011-08-23 |
| US20120065224A1 (en) | 2012-03-15 |
| CA2578880A1 (en) | 2006-03-09 |
| AU2005280738B2 (en) | 2010-11-25 |
| ATE518858T1 (de) | 2011-08-15 |
| WO2006025714A1 (en) | 2006-03-09 |
| MX2007002214A (es) | 2007-05-07 |
| PL1784402T3 (pl) | 2011-12-30 |
| AU2005280738A1 (en) | 2006-03-09 |
| EP1784402B1 (en) | 2011-08-03 |
| JP2008511618A (ja) | 2008-04-17 |
| CN101018788B (zh) | 2010-08-25 |
| KR100946219B1 (ko) | 2010-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1784404T3 (da) | Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling | |
| WO2004087699A3 (en) | Thiazoles useful as inhibitors of protein kinases | |
| WO2004087698A3 (en) | Thiazoles useful as inhibitors of protein kinases | |
| WO2006023515A3 (en) | Novel thiazole inhibitors of fructose 1,6-bisphosphatase | |
| ATE365742T1 (de) | 4-aminothieno(2,3-d) pyrimidin -6-carbonitril- derivative zur verwendung als pde7 inhibitoren | |
| NO20063231L (no) | Pyrido[2,3-D]pyrimidin-2,4-diaminer som PDE 2 inhibitorer | |
| WO2004063151A3 (en) | Novel tyrosine kinase inhibitors | |
| NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| NO20070557L (no) | Ftalazinderivater som PARP-inhibitorer | |
| WO2005037825A3 (en) | Protein kinase inhibitors | |
| NO20070529L (no) | Kinazolindionderivater som parp-inhibitorer | |
| NO20071095L (no) | Hittil ukjente tiofenderivater | |
| NO20070445L (no) | Pyrimidinderivater. | |
| WO2008022286A3 (en) | Small molecule inhibitors of kynurenine-3-monooxygenase | |
| WO2006126082A3 (en) | Pyridine [3,4-b] pyrazinones as pde-5 inhibitors | |
| WO2007058832A3 (en) | Pyrrolo (2, 3-b) pyridine derivatives useful as tec kinase inhibitors | |
| WO2009013348A3 (en) | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions | |
| DK1784402T3 (da) | Pyrrolo[3,2-c]pyridinderivater samt fremgangsmåder til deres fremstilling | |
| WO2006116733A3 (en) | Protein kinase inhibitors | |
| WO2007053844A8 (en) | Compositions and methods for treating inflammatory disorders | |
| BR0313385A (pt) | Derivados de pirimidina-2,4-diona como inibidores de metaloproteinase da matriz | |
| WO2004110990A3 (en) | Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 | |
| WO2006072000A3 (en) | Xanthurenic acid derivative pharmaceutical compositoins and methods related thereto | |
| WO2006124865A3 (en) | Biaryls derivatives useful as modulators of ion channels | |
| DK1805177T3 (da) | Pyrrolo(3,2-C]pyridinderivater og fremgangsmåde til fremstilling deraf |